Health Care & Life Sciences » Biotechnology | Fibrocell Science Inc.

Fibrocell Science Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
60,033.00
37,495.00
29,268.00
17,515.00
17,417.00
14,430
Total Accounts Receivable
28.00
4.00
-
-
-
-
Inventories
597.00
571.00
482.00
-
-
-
Other Current Assets
1,202.00
1,278.00
1,244.00
513.00
485.00
105
Total Current Assets
61,860.00
39,348.00
30,994.00
18,028.00
17,902.00
14,535
Net Property, Plant & Equipment
1,701.00
1,598.00
1,582.00
1,489.00
1,470.00
1,222
Intangible Assets
5,238.00
4,687.00
4,136.00
-
-
-
Other Assets
215.00
1.00
-
65.00
39.00
1
Total Assets
69,014.00
45,634.00
36,712.00
19,582.00
19,411.00
15,758
Accounts Payable
2,958.00
1,124.00
499.00
440.00
862.00
Other Current Liabilities
635.00
2,369.00
14,866.00
2,547.00
3,563.00
Total Current Liabilities
3,593.00
3,493.00
15,365.00
2,987.00
4,425.00
Other Liabilities
15,755.00
11,732.00
7,144.00
8,734.00
5,979.00
Total Liabilities
19,348.00
15,225.00
22,509.00
11,721.00
10,404.00
Common Equity (Total)
49,666.00
30,409.00
14,203.00
7,861.00
9,007.00
Total Shareholders' Equity
49,666.00
30,409.00
14,203.00
7,861.00
9,007.00
Total Equity
49,666.00
30,409.00
14,203.00
7,861.00
9,007.00
Liabilities & Shareholders' Equity
69,014.00
45,634.00
36,712.00
19,582.00
19,411.00

About Fibrocell Science

View Profile
Address
405 Eagleview Boulevard
Exton Pennsylvania 19341
United States
Employees -
Website http://www.fibrocell.com
Updated 07/08/2019
Fibrocell Science, Inc. is an autologous cell and gene therapy company, which engages in translating personalized biologics into medical breakthroughs for diseases affecting the skin and connective tissue. Its clinical and pre-clinical programs include treatments for restrictive burn scars, vocal cord scars, and acne scars. The company was founded on September 1, 2009 and is headquartered in Exton, PA.